We're proud to share that Dr. Iris Dirven and Yenthe Moreel have won the Best Poster Award at the 2025 EADO/World Congress of Melanoma in Athens!
Under the guidance of Prof. Dr. Bart Neyns, they presented results from their dual-center case series on Regorafenib in Caucasian patients with advanced KIT-mutant melanoma. Their data show unprecedented anti-tumor activity and a promising safety profile in this rare patient population. A prospective phase II clinical trial is now recruiting in UZ Brussel to confirm these findings.
Read the complete poster here: